secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0001193125-23-238307
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health reaffirms FY 2023 GAAP EPS >$29.09 and adjusted EPS >$32.85
---------------------------------------------------------------------------

- Officers reaffirm full-year 2023 GAAP net income >$29.09 per share, including ~$3.76 unfavorable items.
- Adjusted net income guidance unchanged at >$32.85 per share, excluding the unfavorable items.
- Reaffirmation made during investor meetings over the next ten days; no new adjustments beyond Q2 2023.
- Guidance does not reflect any additional items other than those reported in Q2 2023 earnings release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523238307/0001193125-23-238307-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312523238307/d523562d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-238307

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer